Cancer associated macrophage-like cells in metastatic renal cell carcinoma predicts for poor prognosis and tracks treatment response in real time

Renal Cell Carcinoma (RCC) is a fatal urological cancer, with one third of patients diagnosed with metastasis, resulting in a 5-year survival of only 12%. Recent advancements in therapies have increased survival in mRCC, but lack efficacy in subtypes, due to treatment resistance and toxic side effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Amama, Adams, Daniel L., Kasabwala, Dimpal M., Tang, Cha-Mei, Ho, Thai H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310728/
https://www.ncbi.nlm.nih.gov/pubmed/37386095
http://dx.doi.org/10.1038/s41598-023-37671-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10310728/
https://www.ncbi.nlm.nih.gov/pubmed/37386095
http://dx.doi.org/10.1038/s41598-023-37671-3

Ejemplares similares